Killing cancer with chemotherapy is a rapidly changing treatment. Using
genomic profiling, or precision medicine, Hoag Lung Cancer Program is
able to provide further targeted approaches to lung cancer care, testing
lung tumors through the nationally recognized Caris Life Sciences laboratory
to determine the most effective treatment option for each individual patient.
As the name implies, precision medicine works by honing in on the precise
molecular mutations that create cancerous tumors. All tumors have molecular
mutations in their DNA. By testing the molecular profile of the tumor
cells, doctors can discover what mutations a particular tumor has and
tailor a treatment specifically to that mutation.
Previously, patients who wanted access to precision medicine in lung cancer
had to go to big academic centers. Now, it is available right here in
Orange County at Hoag Family Cancer Institute.
Through this program, all lung cancer patients will receive a lung tumor
biopsy that will help direct their course of treatment.
As a member of the Caris Centers of Excellence for Precision Medicine Network,
Hoag is able to compare tumor cell data with leading cancer centers at
major academic research facilities across the United States, giving our
patients access to the most advanced clinical trials and treatment options
available today.
This means that patients will know exactly what is causing their tumor
and will have access to the precise treatment to fight it – even
if that treatment is still being developed.
source:
Comments
Post a Comment